Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $1.79 billion. The enterprise value is $1.49 billion.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SION has 45.14 million shares outstanding. The number of shares has increased by 935.60% in one year.
| Current Share Class | 45.14M |
| Shares Outstanding | 45.14M |
| Shares Change (YoY) | +935.60% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 39.24% |
| Float | 16.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.77 |
| P/TBV Ratio | 5.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.61, with a Debt / Equity ratio of 0.03.
| Current Ratio | 20.61 |
| Quick Ratio | 20.14 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.79% and return on invested capital (ROIC) is -22.61%.
| Return on Equity (ROE) | -31.79% |
| Return on Assets (ROA) | -21.74% |
| Return on Invested Capital (ROIC) | -22.61% |
| Return on Capital Employed (ROCE) | -28.32% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.28M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +226.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +226.11% |
| 50-Day Moving Average | 38.11 |
| 200-Day Moving Average | 33.77 |
| Relative Strength Index (RSI) | 49.42 |
| Average Volume (20 Days) | 476,237 |
Short Selling Information
The latest short interest is 3.80 million, so 8.42% of the outstanding shares have been sold short.
| Short Interest | 3.80M |
| Short Previous Month | 3.76M |
| Short % of Shares Out | 8.42% |
| Short % of Float | 23.24% |
| Short Ratio (days to cover) | 9.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -88.98M |
| Pretax Income | -75.27M |
| Net Income | -75.27M |
| EBITDA | -88.34M |
| EBIT | -88.98M |
| Earnings Per Share (EPS) | -$1.88 |
Full Income StatementBalance Sheet
The company has $235.88 million in cash and $8.68 million in debt, giving a net cash position of $301.63 million or $6.68 per share.
| Cash & Cash Equivalents | 235.88M |
| Total Debt | 8.68M |
| Net Cash | 301.63M |
| Net Cash Per Share | $6.68 |
| Equity (Book Value) | 306.83M |
| Book Value Per Share | 6.86 |
| Working Capital | 229.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$66.30 million and capital expenditures -$377,000, giving a free cash flow of -$66.67 million.
| Operating Cash Flow | -66.30M |
| Capital Expenditures | -377,000 |
| Depreciation & Amortization | 647,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -66.67M |
| FCF Per Share | -$1.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |